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Conclusions: Retinal edn2 and ednrA are necessary for 
stress-induced neuroprotection using the light damage model. Retinal 
edn2 knockout mice have defective upregulation of GFAP in Müller 
cells. It may be that edn2 is involved in regulating the Müller glial 
response to stress. As such, future questions are centered on whether 
other Müller cell functions are regulated by edn2.
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Purpose: We have shown previously that recombinant human MANF 
protects photoreceptors in a retinal degeneration rat model carrying 
the S334ter rhodopsin mutation. In the present work, we examined 
the effects of MANF on the expression of 5 ER-stress markers, 
including BiP, IRE1α, PERK, ATF6, and CHOP, in rat retina.
Methods: Recombinant human MANF was expressed in E. coli and 
puri¿ed. MANF (10 µg in 3 µl) was intravitreally injected to the 
left eyes, and the right eyes were injected with 3 µl PBS (phosphate 
buffered saline) as controls. The levels of ER stress markers BiP, 
IRE1α, PERK, ATF6, and CHOP, were assessed by Western blot 
analysis.
Results: We ¿rst examined the expression levels of BiP, IRE1α, 
PERK, ATF6, and CHOP in the retinas of the S334ter (line 3) rats 
during rapid photoreceptor degeneration from postnatal day (PD) 6 
to PD 20. Among the 6 markers, only the level of PERK showed a 
decrease from PD 6 to PD12. Surprisingly, MANF treatment induced 
a dramatic increase in ATF6 by 6 hr post injection (injected at PD9). 
The increase in ATF6 then rapidly declined to control level by 12 
hr post injection. In addition, a signi¿cant increase in CHOP was 
detected at 6 hr, peaked at 12 hr, and lasted to 48 hr post injection. 
No signi¿cant changes were seen in the other 4 proteins. Similar 
increases in ATF6 and CHOP were observed in wild-type Sprague 
Dawley rats after MANF injection.
Conclusions: No signi¿cant changes in ER stress marker were found 
during the rapid photoreceptor degeneration in the S334ter-3 rats, 
suggesting that ER stress does not play a major role in photoreceptor 
degenerations in this model. Intravitreal injection of MANF 
signi¿cantly induces the levels of ATF6 and CHOP.
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Purpose: Visual decline is normally associated to the aging process. 
We search for cellular and molecular processes associated to normal 
aging. In addition, we have previously shown that human proinsulin 
(hPi) delays vision loss, as determined by electroretinography (ERG), 
and retinal degeneration, as determined by photoreceptor counting, 
in the rd10 mouse and the P23H rat models of Retinitis Pigmentosa. 
Our aim is to reveal additional potential bene¿ts of a hPi-based 
treatment in the aged retina.
Methods: Wild type mice (C57BL/6) were studied at 3- to 22-months 
of age. Retinal structure was determined in cryo-sections. Pro-
inÀammatory gene expression was characterized by RT-qPCR. 
Insulin resistance was established in organotypic retinal cultures, 
measuring AKT phosphorylation by western blot. In addition, 
mice were treated by intramuscular injection of adeno-associated 
viral vector, either empty (AAV-Ø) or encoding hPi (AAV-hPi) at 
six month of age. Visual function was evaluated by ERG in 9- to 
18-month old animals.
Results: In comparison with young adult animals, visual function 
decline was evident at 12 months of age, with a 30-40% reduction 
in the amplitude of several ERG waves. In parallel, TNF-α gene 
expression increased 2-4 fold, and cultured retinas did not longer 
show AKT phosphorylation in response to insulin. AAV-mediated 
expression of hPi delayed 3 to 6 month the onset of visual decline at 
mid-age.
Conclusions: Retinal aging involves processes found in normal and 
precocious brain aging, namely low level of chronic inÀammation, 
insulin resistance and functional decline. Neuroprotection with 
hPi provides a potential treatment to maintain visual quality under 
different physiopathological conditions, including aging.
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Purpose: Recent evidence indicates that photoreceptor cell death 
in inherited retinal degeneration is governed by non-apoptotic 
mechanisms (Arango-Gonzalez et al., Plos One., 9(11):e112142, 
2014). These mechanisms involve an over-activation of histone 
deacetylase (HDAC) and are also driving primary cone death in the 
cone-photoreceptor-function-loss (cpÀ1) mouse. In the present study, 
we investigated whether HDAC inhibition could prevent cpÀ1 cone 
loss in vivo.
Methods: CpÀ1 and wt animals (n=11 and n=6, respectively) were 
injected intravitreally, in one eye, at the onset of cone degeneration 
(PN14) with 1nM or 10nM Trichostatin A (TSA), an inhibitor of 
